HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mathias Hänel Selected Research

Doxorubicin (Adriamycin)

8/2016Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
4/2014Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma.
9/2009Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mathias Hänel Research Topics

Disease

21Multiple Myeloma
03/2024 - 08/2006
19Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 09/2008
9Neoplasms (Cancer)
01/2023 - 02/2006
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2023 - 04/2011
5Lymphoma (Lymphomas)
02/2023 - 08/2006
5Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 09/2008
4Leukemia
11/2023 - 09/2008
4Glioblastoma (Glioblastoma Multiforme)
09/2019 - 10/2016
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2024 - 08/2016
3Infections
12/2023 - 12/2015
3Hodgkin Disease (Hodgkin's Disease)
05/2022 - 09/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2019 - 04/2014
2Pneumonia (Pneumonitis)
02/2024 - 12/2015
2Septic Shock (Toxic Shock Syndrome)
02/2024 - 11/2022
2Neutropenia
10/2023 - 02/2006
2Thrombocytopenia (Thrombopenia)
10/2023 - 10/2012
2Residual Neoplasm
09/2023 - 11/2022
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023 - 12/2018
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2021 - 12/2020
2Hemorrhage
12/2015 - 10/2012
1Colitis
02/2024
1Meningoencephalitis
02/2024
1Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2024
1Pulmonary Embolism
02/2024
1Sepsis (Septicemia)
02/2024
1Leukopenia
10/2023
1Anemia
10/2023
1Philadelphia Chromosome
10/2023
1Paraproteinemias (Monoclonal Gammopathy)
01/2023
1Trisomy (Trisomies)
01/2023
1Renal Insufficiency (Renal Failure)
11/2022
1Enteritis
11/2022
1Heart Arrest (Cardiac Arrest)
11/2022
1Bronchiolitis Obliterans Syndrome
01/2022
1Hypertension (High Blood Pressure)
08/2021
1Thrombosis (Thrombus)
08/2021
1Frailty
03/2020
1Splenomegaly
01/2020
1Primary Myelofibrosis (Myelosclerosis)
01/2020

Drug/Important Bio-Agent (IBA)

9Lenalidomide (CC 5013)FDA Link
02/2024 - 02/2010
8Dexamethasone (Maxidex)FDA LinkGeneric
04/2024 - 06/2012
8Rituximab (Mabthera)FDA Link
04/2024 - 09/2008
6Bortezomib (Velcade)FDA Link
04/2024 - 01/2014
6Cytarabine (Cytosar-U)FDA LinkGeneric
04/2024 - 06/2013
4Bevacizumab (Avastin)FDA Link
09/2019 - 10/2016
4Irinotecan (Camptosar)FDA LinkGeneric
09/2019 - 10/2016
4Temozolomide (Temodar)FDA LinkGeneric
09/2019 - 10/2016
4Imatinib Mesylate (Gleevec)FDA Link
01/2019 - 04/2011
4Vincristine (Oncovin)FDA LinkGeneric
08/2016 - 09/2009
4Prednisone (Sone)FDA LinkGeneric
08/2016 - 09/2008
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2016 - 09/2009
3isatuximabIBA
09/2023 - 01/2022
3Melphalan (Alkeran)FDA LinkGeneric
11/2022 - 03/2020
3MethyltransferasesIBA
09/2019 - 10/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
08/2016 - 09/2009
2Monoclonal AntibodiesIBA
02/2024 - 11/2022
2carfilzomibIBA
09/2023 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2018
2Cisplatin (Platino)FDA LinkGeneric
12/2019 - 08/2016
2Thalidomide (Thalomid)FDA Link
12/2015 - 06/2012
2Mitoxantrone (Novantrone)FDA LinkGeneric
06/2013 - 09/2008
2Etoposide (VP 16)FDA LinkGeneric
09/2009 - 09/2008
1elotuzumabIBA
02/2024
1LigandsIBA
11/2023
1KIR ReceptorsIBA
11/2023
1Inotuzumab OzogamicinIBA
10/2023
1EnzymesIBA
10/2023
1bosutinibIBA
10/2023
1Tyrosine Kinase InhibitorsIBA
10/2023
1AnthracyclinesIBA
09/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1ChromatinIBA
01/2023
1tyramine-deoxysorbitolIBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2023
1CohesinsIBA
01/2023
1midostaurinIBA
01/2023
1Neutralizing AntibodiesIBA
01/2023
1isocitric acid (isocitrate)IBA
01/2022
1daratumumabIBA
01/2022
1CPX-351IBA
10/2021
1Uric Acid (Urate)IBA
08/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1AntibodiesIBA
01/2021
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1GalliumIBA
12/2020
1obinutuzumabIBA
12/2020
1Prednisolone (Predate)FDA LinkGeneric
03/2020

Therapy/Procedure

22Therapeutics
04/2024 - 09/2008
10Stem Cell Transplantation
03/2024 - 10/2012
10Drug Therapy (Chemotherapy)
01/2023 - 08/2006
8Cell Transplantation
01/2023 - 09/2008
3Radiotherapy
08/2018 - 04/2014
2Dexa-BEAM protocol
02/2023 - 05/2022
2Transplantation
11/2022 - 09/2008
2Salvage Therapy
12/2019 - 09/2008
1Consolidation Chemotherapy
01/2023
1Immunotherapy
01/2021
1Radioimmunotherapy
01/2020